4//SEC Filing
BRYNELSEN CHARLES 4
Accession 0001179110-19-002637
CIK 0000001800other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:05 PM ET
Size
9.1 KB
Accession
0001179110-19-002637
Insider Transaction Report
Form 4
BRYNELSEN CHARLES
Senior Vice President
Transactions
- Award
Common shares without par value
2019-02-22+15,563→ 44,422 total - Award
Option (right to buy)
2019-02-22+81,578→ 81,578 totalExercise: $75.90From: 2020-02-22Exp: 2029-02-21→ Common shares (81,578 underlying)
Footnotes (2)
- [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,192 on February 22, 2020, 27,193 on February 22, 2021, and 27,193 on February 22, 2022.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001712459
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:05 PM ET
- Size
- 9.1 KB